Inventor
JAKOBOVITS AYA
US188 patents
⚠️ This page may combine multiple inventors who share the name “JAKOBOVITS AYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENSYS INC
26 patentsUS7507541B2Mar 24, 2009
36P6D5: secreted tumor antigen
AGENSYS INC89 citations98
US7494646B2Feb 24, 2009
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC38 citations96
US7361338B2Apr 22, 2008
Methods to inhibit growth of prostate cancer cells
AGENSYS INC40 citations96
US7226594B2Jun 5, 2007
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC25 citations96
US8013128B2Sep 6, 2011
Antibodies and related molecules that bind to PSCA proteins
AGENSYS INC28 citations93
US7968090B2Jun 28, 2011
Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer
AGENSYS INC19 citations93
US7884179B2Feb 8, 2011
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
AGENSYS INC20 citations93
US7667018B2Feb 23, 2010
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC10 citations93
US7641905B2Jan 5, 2010
Methods of inducing an immune response
AGENSYS INC25 citations93
US7628989B2Dec 8, 2009
Methods of inducing an immune response
AGENSYS INC23 citations93
US7622564B2Nov 24, 2009
Prostate stem cell antigen (PSCA) variants and subsequences thereof
AGENSYS INC20 citations93
US7595379B2Sep 29, 2009
Antibodies and related molecules that bind to PSCA proteins
AGENSYS INC34 citations93
US7541442B2Jun 2, 2009
Antibodies and related molecules that bind to PSCA proteins
AGENSYS INC26 citations93
US7405290B2Jul 29, 2008
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC23 citations93
US7244827B2Jul 17, 2007
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
AGENSYS INC20 citations93
US7067130B2Jun 27, 2006
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
AGENSYS INC27 citations93
US6602501B1Aug 5, 2003
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
AGENSYS INC13 citations93
US9314538B2Apr 19, 2016
Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins
AGENSYS INC9 citations92
US9078931B2Jul 14, 2015
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
AGENSYS INC11 citations92
US8013135B2Sep 6, 2011
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC16 citations92
US8008442B2Aug 30, 2011
Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
AGENSYS INC22 citations92
US7947459B2May 24, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US7939503B2May 10, 2011
Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA
AGENSYS INC17 citations92
US7811565B2Oct 12, 2010
Antibodies and related molecules that bind to 161P2F10B proteins
AGENSYS INC20 citations92
US7510840B1Mar 31, 2009
Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody
AGENSYS INC16 citations92
US7459539B2Dec 2, 2008
Antibody that binds zinc transporter protein 108P5H8
AGENSYS INC16 citations92
ABGENIX INC
15 patentsUS6673986B1Jan 6, 2004
Generation of xenogeneic antibodies
ABGENIX INC478 citations99
US6657103B1Dec 2, 2003
Human antibodies derived from immunized xenomice
ABGENIX INC260 citations99
US6458592B1Oct 1, 2002
Production of antibodies using cre-mediated site-specific recombination
ABGENIX INC126 citations99
US6235883B1May 22, 2001
Human monoclonal antibodies to epidermal growth factor receptor
ABGENIX INC831 citations99
US6162963ADec 19, 2000
Generation of Xenogenetic antibodies
ABGENIX INC1,334 citations99
US6150584ANov 21, 2000
Human antibodies derived from immunized xenomice
ABGENIX INC3,069 citations99
US6130364AOct 10, 2000
Production of antibodies using Cre-mediated site-specific recombination
ABGENIX INC521 citations99
US6091001AJul 18, 2000
Production of antibodies using Cre-mediated site-specific recombination
ABGENIX INC502 citations99
US6075181AJun 13, 2000
Human antibodies derived from immunized xenomice
ABGENIX INC3,137 citations99
US5939598AAug 17, 1999
Method of making transgenic mice lacking endogenous heavy chains
ABGENIX INC2,618 citations99
US5985615ANov 16, 1999
Directed switch-mediated DNA recombination
ABGENIX INC346 citations98
US5916771AJun 29, 1999
Production of a multimeric protein by cell fusion method
ABGENIX INC1,034 citations98
US7064244B2Jun 20, 2006
Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom
ABGENIX INC197 citations97
US6207418B1Mar 27, 2001
Production of a multimeric protein by cell fusion method
ABGENIX INC86 citations97
US6114598ASep 5, 2000
Generation of xenogeneic antibodies
ABGENIX INC1,486 citations97
UNIV CALIFORNIA
3 patentsJAPAN TOBACCO INC
1 patent(unassigned)
1 patentCELL GENESYS INC
1 patentRAITANO ARTHUR B
1 patentGUDAS JEAN
1 patentAMGEN FREMONT INC
1 patentShowing the top 50 of 188 patents by PatentIndex Score.